Regents Of The University Of California Guardant Health, Inc. Transaction History

Regents Of The University Of California

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 21, 2020	SELL	$80.32 - $111.8 $10.9 Million - $15.1 Million	-135,273 Closed	0 $0
Q2 2020 Jul 23, 2020	SELL	$60.49 - $97.5 $1.63 Million - $2.62 Million	-26,889 Reduced 16.58%	135,273 $11 Million
Q1 2020 Apr 24, 2020	BUY	$59.04 - $88.81 $5 Million - $7.52 Million	84,666 Added 109.25%	162,162 $11.3 Million
Q4 2019 Feb 10, 2020	SELL	$59.49 - $82.78 $113,625 - $158,109	-1,910 Reduced 2.41%	77,496 $6.06 Million
Q3 2019 Nov 13, 2019	BUY	$62.59 - $110.3 $4.97 Million - $8.76 Million	79,406 New	79,406 $5.07 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Regents Of The University Of California, based on Form 13F filings with the SEC.

Stay updated on Regents Of The University Of California with notifications on news.